EGFR-RAD51 fusion in lung adenocarcinoma with systemic and intracranial response to osimertinib: A case report and review of the literature
Rubens Copia Sperandio, Francinne T. Tostes, Paulo Vidal Campregher, Vítor Ribeiro Paes, Fernando Moura, Gustavo Schvartsman
Topics & Concepts
OsimertinibMedicineTyrosine-kinase inhibitorLung cancerOncologyFusion geneAdenocarcinomaTyrosine kinaseInternal medicineCancer researchCancerGeneReceptorROS1ChemistryBiochemistryLung Cancer Treatments and MutationsLung Cancer Diagnosis and TreatmentGastric Cancer Management and Outcomes